Get started
Author

Atish Bakane

Observed name: Atish N. Bakane
ORCID: 0000-0001-6403-2309
Observed ORCID: 0000-0001-6403-2309
OpenAlex ID: A5024337993
Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease
2020 · Gaurav Kharya, Atish Bakane, et al. · Bone Marrow Transplantation · 29
Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India
2022 · Gaurav Kharya, Sarita R. Jaiswal, et al. · Transplantation and Cellular Therapy · 22
Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India
2021 · Revathi Raj, Fouzia N. Aboobacker, et al. · Frontiers in Immunology · 18
PDF
Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies
2021 · Gaurav Kharya, Atish N. Bakane, et al. · Pediatric Blood & Cancer · 14
Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children
2016 · Ramya Uppuluri, Sreejith Ramachandrakurup, et al. · Pediatric Blood & Cancer · 10
Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide
2017 · Ramya Uppuluri, Sreejith Ramachandrakurup, et al. · Journal of Pediatric Hematology/Oncology · 5
Thiotepa-based reduced toxicity conditioning in combination with post-transplant cyclophosphamide and mTOR inhibitor for heavily transfused acquired severe aplastic anemia in children and young adults: encouraging outcomes of a pilot study
2022 · Gaurav Kharya, Sudhir Sapkota, et al. · Bone Marrow Transplantation · 3
A Comparative Analysis of Low Dose Grafalon ® Versus Thymoglobuline ® as Serotherapy in Hematopoietic Stem Cell Transplant in Pediatric and Young Adult Population
2024 · Garima Nirmal, Gaurav Kharya, et al. · Pediatric Hematology and Oncology · 2
Unmasking the Rarity: A Case Report on Type B Lactic Acidosis in Pediatric Acute Lymphoblastic Leukemia
2024 · Keta Vagha, Atish Bakane, et al. · Cureus · 2
PDF
Shifting paradigms from myeloablation to immune modulation: pre-transplant immune-suppression and post-transplant cyclophosphamide in human leucocyte antigen identical related donor hematopoietic stem cell transplantation for sickle cell disease
2026 · Gaurav Kharya, Garima Nirmal, et al. · Haematologica · 1
PDF
Successful T‐cell‐depleted haploidentical hematopoietic stem cell transplant for a novel NF‐E2 mutation causing inherited thrombocytopenia
2020 · Atish Bakane, Archana Rauthan, et al. · Pediatric Blood & Cancer · 1
PDF
A Single Centre Study from India on the IMPACT on Quality of Life in Thalassaemia Major – HSCT Versus LONG TERM Transfusion
2016 · Revathi Raj, Sreejith Ramachandran, et al. · Transplantation and Cellular Therapy · 1
Second Salvage Hematopoietic Cell Transplant in a Sickle Cell Disease Presenting with Acquired Hypoplastic Anemia of Donor Marrow
2024 · Sudhir Sapkota, Atish Bakane, et al.
PDF
The Thalassemia Syndromes: New Insights
2023 · Saksham Singh, Chittala Kiran Sri, et al. · IntechOpen eBooks
PDF
HLA Identical (Related/Unrelated) Donor Hematopoietic Stem Cell Transplant for Hemoglobinopathies using Pre-transplant Immune Suppression and Post-transplant Cyclophosphamide: Does it Help Consolidate Our Gains?
2023 · Gaurav Kharya, Garima Nirmal, et al. · Research Square
PDF
Ptcy-Based Haploidentical Hematopoietic Cell Transplant for Acquired Severe Aplastic Anemia in Children and Young Adults: A Report from Pediatric Severe Aplastic Anemia Consortium of India
2022 · Gaurav Kharya, Sarita Rani Jaiswal, et al. · Transplantation and Cellular Therapy
Thiotepa Based Reduced Toxicity Conditioning for Heavily Transfused Acquired Severe Aplastic Anemia in Children and Young Adults: Exceptional Outcomes of a Pilot Study
2022 · Gaurav Kharya, Neeraj Teotia, et al. · Transplantation and Cellular Therapy
Acute Myeloid Leukemia with Monosomy 7 in Sickle Cell Disease Post T Cell Replete Haploidentical Hematopoietic Stem Cell Transplant: Brief Report
2020 · Archana Rauthan, Atish Bakane, et al.
Hematopoietic Stem Cell Transplant for Osteopetrosis (TCIRG1) Mutation Using Thiotepa Treosulfan Fludarabine Conditioning: Brief Report
2020 · Archana Rauthan, Atish Bakane, et al.
PDF
A Single Centre Experience on the Use of DONOR Lymphocyte Infusion in Children Transplanted for Benign Disorders
2016 · Revathi Raj, Ramya Uppuluri, et al. · Transplantation and Cellular Therapy
PDF
Works count: 20
Citation count: 108
H-index: 5
I10-index: 5
Year
Topic
Type